C3 and nervous system disorder: In summary, our findings demonstrated that NBO plays a neuroprotective role by reducing the level of C3 in microglia and alleviating microglia‐mediated synaptic pruning, suggesting that NBO therapy might be an effective clinical treatment for ICH patients and targeting microglial C3 may be a potential therapeutic approach for treating neurological disorders caused excessive synaptic elimination.